Italy· 020328151
PROVERA*30 cpr 250 mg flacone
A medicinal product containing medrossiprogesterone, registered in Italy by PFIZER ITALIA Srl, on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Medrossiprogesterone
- Manufacturer
- PFIZER ITALIA Srl
- Country
- Italy (IT)
- ATC code
- —
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic020328151PROVERA*30 cpr 250 mg flaconeEUR 50.25
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Medrossiprogesterone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDepo-ProveraPharmacia & Upjohn Company LLC
- United KingdomAdgyn Medro 5mg tabletsKyowa Kirin Ltd
- FinlandCykrinaWyeth Medica Ireland
- BelgiumDepo-Provera 1000, 1000 mgPfizer
- CzechiaDEPO-PROVERAPfizer, spol. s r.o., Praha
- CanadaAA-MEDROXYAA PHARMA INC
- NetherlandsDepo-Provera 150, suspensie voor injectie 150 mg/mlPfizer B.V.
- Japanメドロキシプロゲステロン酢酸エステル富士製薬工業
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Depocon, Farlutal
- Belgium · Depo-Provera, Provera
- Bulgaria · Фарлутал
- Czechia · Depo-Provera, Provera
- Germany · Depo-Clinovir, Mpa
- Denmark · Depo-Provera, Provera
- Estonia · Farlutal
- Spain · Depo-Progevera, Progevera
- Finland · Farlutal, Provera
- France · Depo Prodasone, Depo Provera
- United Kingdom (Northern Ireland) · Depo-Provera, Medroxyprogesterone Acetate Pfizer
- Croatia · Provera
- Hungary · Depo-Provera, Provera
- Ireland · Depo-Provera, Provera
- Iceland · Depo-Provera
- Luxembourg · Depo-Provera, Provera
- Latvia · Depo-Provera
- Netherlands · Depo-Provera, Provera
- Norway · Depo-Provera, Provera
- Poland · Depo-Provera, Provera
- Portugal · Depo-Provera 150
- Sweden · Depo-Provera, Provera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/78059a75-a7bb-469b-8b27-53193d0495ea GET /v1/drugs/78059a75-a7bb-469b-8b27-53193d0495ea?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 50.25,
"source": "aifa",
"currency": "EUR",
"strength": "MEDROSSIPROGESTERONE 250MG 30 UNITA' USO ORALE",
"substance": "Medrossiprogesterone",
"equivalence_group": "OCE",
"transparency_flag": null
}See everything about medrossiprogesterone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.